Appointment of Joint Corporate Broker

In brief · summary, not quotable

Novacyt S.A. announced the appointment of Singer Capital Markets as a joint corporate broker, effective immediately. Singer Capital Markets will collaborate with SP Angel, the company's existing Nominated Adviser and joint corporate broker. Novacyt is listed on EURONEXT GROWTH: ALNOV and AIM: NCYT. The company is headquartered in Le Vésinet, France, with offices in the UK, Singapore, the US, and Canada, and has a commercial presence in over 65 countries.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your NCYT notes

Paris, France, and Manchester, UK - 15 September 2025 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), the international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the appointment of Singer Capital Markets as joint corporate broker to the Company, with immediate effect.

Singer Capital Markets will work alongside SP Angel, the Company's Nominated Adviser and existing joint corporate broker.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.